(Nle27)-GRF (1-29) amide (human) incorporates norleucine to enhance resistance to enzymatic breakdown while maintaining native-like signaling domains. The substitution aids in exploring structure-activity relationships within growth-regulating peptides. Its amide terminus contributes to improved conformational stability. Researchers apply this analog to investigate receptor-binding determinants and peptide hormone biosynthesis.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.